Quarterly report pursuant to Section 13 or 15(d)

Other current assets (Tables)

v3.24.2.u1
Other current assets (Tables)
6 Months Ended
Jun. 30, 2024
Other current assets  
Summary of other current assets

June 30, 

December 31, 

    

2024

2023

Research and development credits receivable

 

$

21,125

$

46,098

Prepayments

 

10,651

9,954

Clinical materials

 

1,278

1,329

VAT receivable

305

Other current assets

 

3,287

2,412

$

36,646

$

59,793